New female contraceptive under development: end-user preferences revealed in web-based survey

FHS
July 26, 2023
9:01 am

Researchers investigated prospective end-user preferences for an on-demand, non-hormonal female contraception.

‘Constitutional arguments fail’: Government lawyers slam suits from Bristol Myers, Janssen over drug price negotiations

While stressing that the new government price negotiation program is strictly voluntary, government lawyers made clear in a New Jersey federal court brief filed last

October 18, 2023

Lawmakers push to let telehealth providers keep prescribing stimulants and addiction treatment

Two Democratic lawmakers are working to preserve health providers’ right to prescribe controlled substances via telehealth, including stimulants for ADHD and buprenorphine for opioid addiction.

September 23, 2024

The business of CRISPR’d medicine: Not great

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m really

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.